Curing Rare Skin Diseases with NueSKIN

The team aims to target a group of rare genetic skin diseases called Epidermolysis Bullosa (EB) with a topical gene editing approach. Patients with EB have fragile skin that easily blisters and develops non-healing painful wounds leading to increased mortality. 

Back to Award Directory